'Strongest evidence yet' that being obese causes depression

November 12, 2018

New research released today from the University of South Australia and University of Exeter in the UK has found the strongest evidence yet that obesity causes depression, even in the absence of other health problems.

The research, published in the International Journal of Epidemiology, shows that the psychological impact of being overweight causes depression, rather than associated illnesses such as diabetes.

Researchers looked at UK Biobank data from more than 48,000 people with depression, comparing them with a control group of more than 290,000 people born between 1938 and 1971, who provided medical and genetic information.

Hospital data and self-reporting were used to determine whether people had depression.

Director of the Australian Centre for Precision Health, UniSA Professor Elina Hypponen, who co-led the study, said the team took a genomic approach to their research.

"We separated the psychological component of obesity* from the impact of obesity-related health problems using genes associated with higher body mass index (BMI), but with lower risk of diseases like diabetes," Prof Hypponen says.

"These genes were just as strongly associated with depression as those genes associated with higher BMI and diabetes. This suggests that being overweight causes depression both with and without related health issues - particularly in women"

At the other ends of the BMI spectrum, very thin men are more prone to depression that either men of normal weight or very thin women.

"The current global obesity epidemic is very concerning," Prof Hypponen says. "Alongside depression, the two are estimated to cost the global community trillions of dollars each year.

"Our research shows that being overweight doesn't just increase the risks of chronic diseases such as cancer and cardiovascular disease; it can also lead to depression," Prof Hypponen says.
-end-
Notes to media

The UK Biobank is a study of 500,000 individuals aged between 37 and 73 years recruited from across the UK between 2006-2010. Genetics are available for all individuals.

*Obese individuals are classified as people with a body mass index (BMI) greater than 30 kg/m². BMI is calculated by dividing your weight in kilograms by your height, in metres squared.

Media contact: Professor Elina Hypponen email elina.hypponen@unisa.edu.au">elina.hypponen@unisa.edu.au

Candy Gibson mobile +61 434 605 142 email mailto:candy.gibson@unisa.edu.au">candy.gibson@unisa.edu.au

University of South Australia

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.